Payer

CMS has approved Georgia's plan to transition to a state-based ACA exchange called Georgia Access. 

Humana's board of directors authorized a cash dividend of $0.885 per share to be paid on Oct. 25. 

From UnitedHealthcare announcing a start date for its national gold-card program to a California payer cutting nearly a quarter of its requirements, here are eight updates on prior authorization Becker's has reported since July 11:

The CEOs of the six largest for-profit insurers have different perspectives on Medicare Advantage. 

A swirl of challenges is looming for Medicare recipients ahead of the annual enrollment period beginning Oct. 15.

Elevance Health is launching Mosaic Health, a primary care venture with private equity firm Clayton, Dubilier & Rice. 

In 2023, more than 61% of Ozempic prescriptions went to patients with commercial health insurance, and less than 10% of all semaglutide prescriptions went to Medicaid enrollees, according to a study published Aug. 2 in JAMA Health Forum.

Centene is the most likely to overturn a prior authorization denial decision when appealed, while Humana is the least likely, according to a KFF analysis.

The Medicare Advantage business is facing major challenges — government scrutiny is rising, CMS regulations and payments are tightening, the cost of care is rising and negative media coverage abounds.

Here are 11 updates on UnitedHealth Group and its subsidiaries that Becker's has reported since July 22: